Institutional investors control 36.75% of the outstanding shares in AVEO. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $2.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POLAR CAPITAL LLP Bought 3.9 Million shares of Aveo Pharmaceuticals Inc
PROSIGHT MANAGEMENT LP Bought 1.1 Million shares of Aveo Pharmaceuticals Inc